Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers.

Pathobiology : journal of immunopathology, molecular and cellular biology - 1 Jan 2018

Venesio Tiziana, Siravegna Giulia, Bardelli Alberto, Sapino Anna

Abstract excerpt

Cancer is a spatial and temporal dynamic disease where differently evolving genetic clones are responsible for progression. In this landscape, the genomic heterogeneity of the primary tumours can be captured by deep-sequencing representative spatial samples. However, the recognition of genetic alterations responsible for tumour evolution remains a challenging task. Recently, the "liquid biopsy" was recognized as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colonic Neoplasms

Share to DNA, Neoplasm

Share to Genomics

Share to Liquid Biopsy

Share to Neoplastic Cells, Circulating

Share to Prognosis

Source

Identifiers

PMID: 28614831
DOI: 10.1159/000473882

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers.PMID 28614831Read ↗

Liquid Biopsy: Approaches to Dynamic Genotyping in CancerSemantic proximity Read ↗

Cell‐free circulating tumour DNA as a liquid biopsy in breast cancerSemantic proximity Read ↗

Liquid Biopsy in the Clinical Management of CancersSemantic proximity Read ↗

The potential of liquid biopsies for the early detection of cancerSemantic proximity Read ↗

The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer.Semantic proximity Read ↗

Toward liquid biopsies in cancer treatment: application of circulating tumor DNASemantic proximity Read ↗

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.Semantic proximity Read ↗

Heterogeneity and tumor evolution reflected in liquid biopsy in metastatic breast cancer patients: a reviewSemantic proximity Read ↗

Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapiesSemantic proximity Read ↗

[Liquid biopsy in colorectal cancer : An overview of ctDNA analysis in tumour diagnostics].Semantic proximity Read ↗

Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review)Semantic proximity Read ↗

Liquid biopsy enters the clinic - implementation issues and future challenges.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.